Seeking Alpha

Johnson & Johnson's (JNJ +0.5%) subsidiary Alza Corp. and Janssen Pharmaceutica NV agree to...

Johnson & Johnson's (JNJ +0.5%) subsidiary Alza Corp. and Janssen Pharmaceutica NV agree to transfer world-wide rights for the premature ejaculation treatment Priligy to drug developer Furiex Pharmaceuticals (FURX +9.3%).
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector